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Abstract
Telomere length shortens with cellular division, and leukocyte telomere length is used as a marker for systemic telomere
length. The hippocampus hosts adult neurogenesis and is an important structure for episodic memory, and carriers of the
apolipoprotein E e4 allele exhibit higher hippocampal atrophy rates and differing telomere dynamics compared with non-
carriers. The authors investigated whether leukocyte telomere length was associated with hippocampal volume in 57
cognitively intact subjects (29 e3/e3 carriers; 28 e4 carriers) aged 49–79 yr. Leukocyte telomere length correlated inversely
with left (rs=20.465; p=0.011), right (rs=20.414; p=0.025), and total hippocampus volume (rs=20.519; p=0.004) among
APOE e3/e3 carriers, but not among e4 carriers. However, the e4 carriers fit with the general correlation pattern exhibited by
the e3/e3 carriers, as e4 carriers on average had longer telomeres and smaller hippocampi compared with e3/e3 carriers. The
relationship observed can be interpreted as long telomeres representing a history of relatively low cellular proliferation,
reflected in smaller hippocampal volumes. The results support the potential of leukocyte telomere length being used as a
biomarker for tapping functional and structural processes of the aging brain.
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Introduction
Telomeres are stretches of repetitive non-coding sequences,
constituting the ends of linear chromosomes. As cells divide, the
process of chromosomal replication inevitably leads to telomere
shortening due to the end-replication problem. If a critical length
is reached, the cell will either undergo apoptosis or enter a state of
replicative senescence [1,2]. This means that telomere length (TL)
carries information concerning both replicative history and
potential; properties which have generated a great deal of interest
for telomere research. Leukocyte TL has generally been accepted
as a measurement of systemic TL and has in the last decade been
found to be associated with several age-related disorders and
attributes; e.g., cardiovascular disease, cancer, and dementia
[3,4,5].
Apolipoprotein E (APOE) is a polymorphic gene with three
common alleles: e2, e3, and e4, with typical population
frequencies of approximately 5–10%, 70–85% and 10–25%,
respectively. The APOE e4 allele is a well-established genetic risk
factor for Alzheimer’s disease (AD) and influences episodic
memory negatively in aging individuals, even in the absence of
AD or mild cognitive impairment [6,7]. We have previously
shown that among middle-aged non-demented subjects, leukocyte
TL was longer among APOE e4 carriers compared with non-e4
carriers, and further that worse episodic memory was associated
with longer leukocyte TL among e4 carriers [8]. Episodic memory
depends to a large degree on the hippocampus, and several studies
have found volumetric differences of the hippocampus between
carriers and non-carriers of the APOE e4 allele. Smaller
hippocampi among e4 carriers have been most consistently found
among AD patients, but have also been observed among
cognitively healthy individuals [9,10]. Hippocampal memory
functions are among adults typically found to be positively
correlated to the volume of this brain region [11]. Cell turnover
in the hippocampus is different with regards to most other regions
in the brain as it is one of the few sites to host adult neurogenesis,
believed to be important for learning and memory processes
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proliferation allows for the possibility of telomere involvement, in
its capacity as a determinant of replicative potential.
With the aforementioned as background, we set out to explore
the potential relationship between hippocampal volume, as
determined by magnetic resonance imaging (MRI), and leukocyte
TL in both carriers and non-carriers of the APOE e4 allele. The
sample was drawn from the Betula study on memory and aging,
located in northern Sweden, and consisted of 57 cognitively intact
subjects, out of whom 29 carried the e3/e3 genotype, and 28
carried the e4 allele.
Results
General characteristics of the subjects participating in this study
can be seen in Table 1. The mean age of the participants was
65.8 yr (SD=8.2; ranging from 49 to 79), with 63% being females
(age, males=61.7 yr, SD=8.9; females=61.5 yr, SD=8.0;
p=0.935). There were no significant differences between the 29
APOE e3/e3 and 28 APOE e4 carriers regarding age, education,
gender distribution, or any of the health parameters. Age-adjusted
leukocyte TL was significantly longer among e4 carriers (mean
difference of 351 bp, p=0.039), consistent with observations in the
sample of which the current sample is part of [8]. TL decreased
with increasing age (17 bp/year) in the full sample, but non-
significantly (p=0.118). Hippocampus volume (total) among e3/e3
carriers showed a negative correlation with age (rs=20.404,
p=0.030), but there was no association between age and
hippocampus volume among e4 carriers (rs=20.054 p=0.783).
Hippocampal volumes tended to be smaller among e4 carriers, but
the differences were not statistically significant (Table 1). (For more
detailed analysis on hippocampal structural data in this sample, see
Lind et al. 2006a.)
Analyzing leukocyte TL (adjusted for age) and hippocampus
volume (adjusted for age and body size) showed that among e3/e3
carriers, TL was significantly inversely correlated with hippocam-
pus volume (Fig. 1); with left (rs=20.465, p=0.011), right
(rs=20.414, p=0.025) as well as total volume (rs=20.519,
p=0.004). No significant correlations between hippocampus
volume and leukocyte TL were found among the e4 carriers (left,
rs=0.090, p=0.651; right, rs=0.209, p=0.286; total, rs=0.134,
p=0.498; Fig. 1). Stratifying e3/e3 carriers by gender revealed
similar, but non-significant, correlation coefficients among men
(n=11) and women (n=18); indicating that both genders
contributed to the observed correlation (males: left, rs=20.391,
p=0.235; right, rs=20.391, p=0.235; total, rs=20.427,
p=0.190; women: left, rs=20.377, p=0.123; right, rs=20.340,
p=0.168; total, rs=20.445, p=0.064). Among e4 carriers, no
significant correlations were observed after stratifying for gender
(males, n=10: left, rs=0.285, p=0.425; right, rs=0.261, p=0.467;
total, rs=0.152, p=0.676; women, n=18: left, rs=0.023,
p=0.929; right, rs=0.326, p=0.186; total, rs=0.226, p=0.367).
Raising the MMSE inclusion criteria from $24 to $26, leading to
exclusion of 5 e3/e3 and 5 e4 carriers, did not alter the
significances of the correlations (e3/e3: left, rs=20.463,
p=0.023; right, rs=20.601, p=0.002; total, rs=20.577,
p=0.003; e4: left, rs=0.102, p=0.644; right, rs=0.278,
p=0.199; total, rs=0.194, p=0.376). Considering the document-
ed effect of age on both TL and hippocampal volume, age is a
significant confounder in the analyses. Not taking the confounding
effect of age and body/head size into account, i.e., performing the
analyses completely unadjusted, weakened the correlations among
e3/e3 carriers and made them non-significant (e3/e3: left,
rs=20.299, p=0.108; right, rs=20.247, p=0.188; total,
rs=20.310, p=0.096; e4: left, rs=0.215, p=0.271; right,
rs=0.257, p=0.186; total, rs=0.226, p=0.248); showing that for
TL to be significantly associated with hippocampal volume among
e3 homozygotes, age has to be taken into account (correlations
among e3/e3 carriers remained significant if age, but not body/
Table 1. General characteristics of study participants.
Full Sample (n=57) APOE e3/e3 carriers (n=29) APOE e4 carriers (n=28) p
Age, years (SD) 61.6 (8.2) 62.1 (8.5) 61.1 (8.1) 0.664
Gender, male/female (% male) 21/36 (37) 11/18 (38) 10/18 (36) 0.862
Education, years (SD) 10.4 (3.4) 10.2 (3.3) 10.6 (3.5) 0.631
BMI, kg/m
2 (SD) 26.1 (3.2) 26.2 (3.2) 25.9 (3.3) 0.718
Smokers, n (%) 13 (23) 6 (21) 7 (25) 0.698
Systolic blood pressure, mmHg (SD) 143.2 (16.9) 143.6 (15.2) 142.7 (18.8) 0.835
Diastolic blood pressure, mmHg (SD) 82.4 (9.3) 82.9 (9.5) 81.9 (9.2) 0.667
Hypertension, n (%)
a 34 (60) 18 (62) 16 (57) 0.705
Heart disease, n (%) 11 (19) 6 (21) 5 (18) 0.786
Diabetes (type 2), n (%) 2 (4) 1 (3) 1 (4) 0.980
Prescription drugs (SD) 1.2 (1.4) 1.1 (1.3) 1.3 (1.5) 0.702
MMSE score (SD) 28.1 (1.6) 27.9 (1.8) 28.2 (1.5) 0.571
Left hippocampus volume, mm
3 (SD)
b 2757 (284) 2750 (274) 2757 (288) 0.931
Right hippocampus volume, mm
3 (SD)
b 2895 (356) 2959 (371) 2827 (333) 0.162
Total hippocampus volume, mm
3 (SD)
b 5652 (565) 5709 (587) 5583 (537) 0.403
Leukocyte telomere length, bp (SD)
c 5573 (644) 5401 (537) 5752 (705) 0.039
All values are means unless otherwise stated. MMSE, Mini-mental state examination; SD, standard deviation.
aBlood pressure $140/90 or taking antihypertensive medication.
bAdjusted for body (and head) size and age.
cAdjusted for age.
doi:10.1371/journal.pone.0034292.t001
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not reveal any confounding of the correlation between TL and
hippocampus volume by any of the health parameters listed in
Table 1.
Discussion
In the present study, we investigated whether leukocyte TL had
any relationship with hippocampus volume among 57 non-
demented individuals, aged 49 to 79 yr. In our sample of 29 e3/
e3 carriers, TL was inversely correlated with hippocampus
volume. Among the 28 e4 carriers, no correlation was present;
although, as a group the e4 carriers fit with the correlation pattern
found among e3/e3 carriers as they in general had longer TL and
smaller hippocampi, compared with e3/e3 carriers.
Hippocampal volumes tended to be smaller among APOE e4
carriers, but not significantly. However, as shown by Lind et al.
[9], e4 carriers in this sample aged 65 yr and below had
significantly smaller right hippocampal volumes compared with
e3/e3 carriers in the same age span. Other studies have reported
similar observations, finding that the e4 allele is associated with
smaller hippocampi and increased hippocampal atrophy rates
among e4 carriers, compared with non-carriers [10,14]. This is
interesting in context of our findings, as the suppressive influence
the e4 allele appears to have on the hippocampus volume might
explain the discrepancy in our findings: that of no association
among e4 carriers between TL and hippocampus volume while at
the same time observing a moderate to strong corresponding
association among e3/e3 carriers. Possibly related to this e4 effect
is the by us previously postulated hypothesis of an anti-
proliferative, TL conserving, effect among middle-aged e4 allele
carriers [8]. The e4 allele is associated with immunomodulatory
effects, influencing both innate and adaptive immune responses,
and it has been suggested that aberrant immunomodulatory
activities may be associated with the role of APOE e4 in AD [15].
Such effects can potentially influence both leukocyte TL and
hippocampal volume, and thus alter the relationship between
them. Also, it may be that a weaker association is present among
e4 carriers but that we lacked sufficient power to detect it.
In contrast to our findings, Grodstein et al. [16] reported a
positive relationship between leukocyte TL and hippocampus
volume. However, their sample was smaller, older (mean
age=79.2), only females, not taking APOE genotype into account,
and included 7 (out of 26) participants with mild cognitive
impairment (MCI). Considering that they also reported data
showing that their participants with MCI had both smaller
hippocampi and shorter TL (compared with the cognitively intact
subjects), the inclusion of these subjects in their data analysis on
the relationship between TL and hippocampal volume might to a
large extent have explained their finding of a positive correlation.
Our sample included no MCI cases, only cognitively healthy
subjects.
Several studies that have compared TLs between different
tissues in the same individuals have observed correlations between
them; i.e., individuals with relatively long leukocyte TL have
relatively long TLs in other tissues as well, although not necessarily
of similar lengths in absolute terms [5,17,18]. Together with our
findings, this suggests that non-demented e3/e3 carriers with
relatively small hippocampi and long leukocyte TLs may also have
relatively long TLs in hippocampal cells. To our knowledge, only
Figure 1. Correlations between leukocyte TL and hippocampal volume among APOE e3/e3 and APOE e4 carriers. Leukocyte TL was
adjusted for age. Hippocampal volume was adjusted for body (and head) size and age. Regression lines only shown for significant Spearman
correlations.
doi:10.1371/journal.pone.0034292.g001
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et al. [19] analyzed samples taken from AD patients (with
unknown APOE status) and they found their hippocampal
telomeres to be on average 49% longer compared with
hippocampal tissue from age-matched non-demented subjects.
Although their paper did not contain any volumetric information
regarding the hippocampi which were sampled, a consistent
finding among AD patients is the exhibition of smaller hippocampi
compared with those of age-matched controls [20]. Under this
assumption, their findings are in line with our observed inverse
relationship between leukocyte TL and hippocampus volume. In
addition to measuring hippocampal TL, Thomas et al. also
measured leukocyte TL in Alzheimer’s cases (and found them to
be shorter compared with controls), but this was unfortunately not
the same cases as they measured hippocampal TL in [19].
Therefore, the differences and correlations between leukocyte TL
and hippocampal TL in AD patients in the study by Thomas et al
is unknown.
Seeing as TL to some degree reflects historical proliferative
activity, the finding by Thomas et al. [19] may be indicative of a
relatively low level of cellular replication in the hippocampus of
AD patients. A low activity of cellular division can in general be
expected to coincide with a lower volume of the tissue in question.
Further, cellular replication in the hippocampus includes adult
neurogenesis, a process believed to be of importance for memory
and learning and shown to be reduced among AD patients [12]. If
the finding of Thomas et al. [19] indeed reflects a lower degree of
hippocampal neurogenesis, and if hippocampal TL is correlated
with leukocyte TL, then it can be hypothesized that leukocyte TL
would be inversely associated with hippocampal functions
influenced by adult neurogenesis. In line with this hypothesis is
our recently published findings, where we presented results
showing an inverse relationship between leukocyte TL and
episodic memory tasks, a memory system which depends on the
hippocampus for proper functioning. This inverse relationship was
significant among e4 carriers, and borderline significant among
e3/e3 carriers [8].
TL was significantly longer among carriers of the APOE e4
allele, as reported in our previous study [8] (which also included
the individuals taking part in this study). As mentioned above, we
speculated that this may be due to an anti-proliferative, TL
conserving, effect exerted by the e4 allele. It is also possible, as the
e4 allele has shown immunomodulatory properties and that
different subsets of leukocytes to some degree have different TL
[21,22,23], that the e4 allele influences leukocyte subset ratios and
subsequently leukocyte TL. However, there are, to our knowledge,
no studies indicating that the APOE genotype influences leukocyte
subset ratios. The lack of information regarding leukocyte subsets
ratios is a potential limitation of the study.
In summary, we hypothesize that proliferative activity is the key
to our observed inverse relationship between leukocyte TL and
hippocampus volume among APOE e3/e3 carriers, as well as part
of the explanation as to why e4 carriers as a group fit with the
same inverse relationship. Low activity of proliferation can explain
long telomeres coinciding with relatively small hippocampal
volumes and fits with our previous findings linking long leukocyte
TL with poor performance of episodic memory, a memory system
believed to be dependent on adult neurogenesis taking place in the
hippocampus. This hypothesis is also compatible with what was
found by Thomas et al. [19]. Our findings warrant further studies
to replicate our observations and further expand upon them, as
they show the potential of TL acting as a biomarker for processes
within the brain related to both functional and structural changes.
Extended knowledge about details of TL and TL attrition rates in
both the brain and leukocytes, among both healthy and diseased,
will potentially provide valuable insight into the processes
governing the aging of the brain, and how these possibly can be
tapped by measurement of TL.
Materials and Methods
Ethics Statement
All subjects gave written informed consent, all clinical
investigations were conducted according to the principles
expressed in the declaration of Helsinki, and the study was
approved by The Regional Ethical Review Board in Umea ˚,
Sweden.
Study participants
This study included a sample of 57 individuals (21 males, 36
females), aged 49 to 79; all recruited from the Betula study. The
Betula study is an ongoing prospective cohort study initiated in
1988 aimed at exploring various aspects of memory, health and
aging. To date, approximately 4500 participants have been
enrolled in the Betula study, all randomly selected from the
population registry of Umea ˚ municipality, Sweden. The study
population has been validated to conform well with the general
population of northern Sweden. Exclusion criteria for enrollment
into the Betula project were dementia, mental retardation, serious
visual or auditory handicaps, not having Swedish as a mother
tongue, or any other feature that would compromise the ability to
comply with the study protocol (for full details regarding the Betula
study, see [24,25]). Sixty subjects were recruited from the Betula
pool of subjects for participation in a MRI-based multiple outcome
study. Thirty subjects were APOE e3/e3 carriers, 20 e3/e4 carriers
and 10 were e4/e4 carriers. APOE e4 homozygotes were recruited
initially. Following this, age-, gender-, and education-matched e3/
e3 and e3/e4 carriers were recruited. All subjects were non-
demented (Mini-Mental State Examination $24; [26]) and
cognitively intact [25,27]. 57 subjects were eligible for participa-
tion within the present study. This study sample of 57 individuals
was also part of the larger sample studied in Wikgren et al. [8] and
Lind et al. [9,27]. For more details concerning this sample, see
Lind et al. [27].
Laboratory procedures
Leukocyte DNA was extracted from whole blood using standard
procedures. All blood samples were drawn within a 5 year time-
frame of the MRI examination. APOE genotyping was carried out
using a one-stage PCR method, as previously described [7].
Leukocyte TL was measured using a quantitative real-time PCR
as described earlier [28,29]. In short, each DNA sample was
amplified on two parallel 96-well PCR plates; one amplifying
telomere repeats and the other amplifying a single copy gene (b2-
globin). The ratio of the mean telomere repeat copy number to the
mean single copy gene copy number (T/S ratio) as related to that
of a reference sample (DNA from the cell line CCRF-CEM)
reflects relative TLs. Relative TLs (measured in relative T/S
ratios) were converted to telomere restriction fragment lengths
(measured in base pairs) based on correlation data derived from
samples measured using both quantitative real-time PCR and the
conventional southern blot method. Plasma cotinine was measured
on the IMMULITEH 2000 Immunoassay System (Siemens
Medical Solutions Diagnostics, Los Angeles, CA). Cotinine is the
major metabolite of nicotine, and measurement of it is the favored
method of detecting use of tobacco products [30]. Measured
plasma cotinine values (25 ng/mL was used as cutoff) together
Telomere Length and Hippocampal Volume
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rizing individuals as smoker or non-smoker.
Imaging methods
Magnetic resonance imaging was performed using a Philips
Intera 1.5 T scanner (Philips Medical Systems, Netherlands).
Results from structural scans carried out on this sample have been
reported previously [9]. A total of 124 coronal slices (1.8 mm
thickness) were acquired using a T1-weighted 3D gradient echo
(TR=24 ms, TE=6 ms, flip angle=35u,
FOV=180 mm6180 mm). Images were corrected for undesir-
able effects of head tilt, rotation, and pitch using Brain Image
5.2.5. To achieve isotropic voxel size, bicubic interpolation
between the slices was performed using Matlab 6.1 (Mathworks
Inc., MA, USA). The hippocampus was traced manually on the
coronal slices by J.L. using NIH Image 1.20. All measurements
were performed blinded to the characteristics of the study subjects.
Further details concerning the imaging method and hippocampus
volume determination are available in Lind et al. [9].
Statistical analysis
Means were compared using the independent-samples t-test.
Distributions of categorical variables were tested using the Pearson
chi-square test. The rate of TL shortening with age was
determined using linear regression. To avoid undue influence of
outliers, and due to low number of participants in each APOE
subgroup, Spearman’s rho (non-parametric) was used to evaluate
correlations between TL and hippocampus volume, and between
age and hippocampus volume. TL was age adjusted, and body
height was used to adjust hippocampal volumes for differences in
body (and head) size via analysis of covariance [31]. Hippocampal
volumes were also age-adjusted. P-values below 0.05 were
considered significant. All statistical analyses were performed
using PASW Statistics 18.0 (SPSS Inc., Chicago, IL).
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